Metabolic outcomes a | DM use | Â | Analysis Population | Â | Boys | Â | Girls | ||
---|---|---|---|---|---|---|---|---|---|
N | Unadjusted OR (95% CI) | N | Adjusted OR (95% CI) b | N | Adjusted OR (95% CI) c | N | Adjusted OR (95% CI) c | ||
Abdominal obesity | Slope d | 8114 | 1.00 (0.89–1.13) | 7966 | 1.05 (0.92–1.19) | 3966 | 0.97 (0.81–1.16) | 4000 | 1.12 (0.94–1.34) |
Intercept |  | 1.49 (1.32–1.67) |  | 1.53 (1.35–1.75) |  | 1.30 (1.09–1.56) |  | 1.85 (1.53–2.24) | |
High BP e | Slope | 8425 | 1.01 (0.89–1.14) | 7693 | 1.04 (0.91–1.20) | 3809 | 1.13 (0.94–1.36) | 3884 | 0.96 (0.78–1.17) |
Intercept |  | 1.18 (1.04–1.33) |  | 1.08 (0.94–1.25) |  | 1.15 (0.96–1.38) |  | 1.01 (0.81–1.26) | |
Dyslipidemia | Slope | 6248 | 1.07 (0.93–1.23) | 5001 | 1.00 (0.85–1.18) | 2469 | 1.04 (0.82–1.32) | 2532 | 0.93 (0.73–1.17) |
Intercept |  | 1.30 (1.14–1.48) |  | 1.28 (1.08–1.51) |  | 1. 42 (1.13–1.78) |  | 1.08 (0.84–1.39) | |
Insulin resistance | Slope | 6797 | 0.96 (0.85–1.09) | 5435 | 1.00 (0.87–1.16) | 2728 | 1.22 (1.00–1.50) | 2707 | 0.83 (0.68–1.02) |
Intercept |  | 1.35 (1.20–1.52) |  | 1.16 (1.00–1.35) |  | 1.15 (0.93–1.41) |  | 1.12 (0.90–1.41) | |
MetS | Slope | 6843 | 1.21 (1.01–1.46) | 5288 | 1.30 (1.04–1.62) | 2636 | 1.62 (1.17–2.24) | 2652 | 1.08 (0.80–1.47) |
Intercept |  | 1.55 (1.30–1.84) |  | 1.50 (1.21–1.85) |  | 1.58 (1.20–2.11) |  | 1.35 (0.97–1.87) |